A Trial of Tadalafil and Glycemic Traits

Completed · Phase 3 · Has a placebo group

Conditions studied: Cardiovascular Disease, Insulin Resistance, Glucose Intolerance, Obesity

In brief

The purpose of this study is to find out if tadalafil can help overweight and obese people metabolize blood sugar more efficiently. The investigators also want to find out if 20 mg/day of tadalafil for 3 months is safe to take without causing too many side effects. The investigators are plan to enroll 100 subjects at Massachusetts General Hospital (MGH).

Key facts

Study ID
NCT01444651
Run by
Thomas J. Wang, MD
People needed
73
Starts
2011-08-01
Expected to finish
2013-03-01
Last updated by the study team
2017-01-30

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.